secwatch.observer — SEC 8-K summary
======================================

Issuer:     PFIZER INC (PFE)
CIK:        0000078003
Form:       8-K
Filed at:   2022-04-12T23:59:59+00:00
Accession:  0000078003-22-000057
Event type: leadership
Sentiment:  neutral
Materiality: 0.80
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Pfizer names David M. Denton as CFO effective May 2, 2022
---------------------------------------------------------

- David M. Denton named CFO, EVP effective May 2, 2022, succeeding Frank D'Amelio after 15-year career.
- Compensation: $1.25M base salary, $1.25M target cash incentive (pro-rated for 2022).
- One-time $5M cash payment (repayable if voluntary resignation within 1 year), RSUs valued at $3.25M, and $9.75M Supplemental Plan credit.
- Denton brings 20+ years healthcare experience; previously CFO at Lowe's and CVS Health.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/78003/000007800322000057/0000078003-22-000057-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/78003/000007800322000057/pfe-20220411.htm
  HTML page:      https://secwatch.observer/filing/0000078003-22-000057

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer